Corey’s Journey

Corey had a large tumour in his abdomen and the cancer had spread to his bones and bone marrow. Corey received 8 doses of chemotherapy, a complex 6 hour operation to remove the tumour, stem cell rescue with high dose chemotherapy and radiotherapy. His family were advised that Corey would need to respond to each stage of a 6 month treatment plan to be eligible to join a clinical trial for immunotherapy in the UK. Given the difference in treatment for immunotherapy in America, his parents opted for Corey to receive three immunotherapy drugs, as opposed to the one or two available drugs as part of the randomised clinical trial in the UK. Thanks to the generosity of Corey’s local community who donated to Corey’s appeal with the charity J-A-C-K and general funds from the Neuroblastoma Alliance, Corey was able to start his immunotherapy treatment at the Children’s Hospital of Philadelphia in November 2011. He made remarkable progress through every round of the gruelling treatment and currently has no detectable disease. Despite everything Corey has gone through there is no guarantee that the cancer will not return. If the cancer were to come back, the UK doctors would not have a protocol to treat it in a curative way. The Ashcroft family would have the use their privately raised funds and would launch a new fundraising appeal. Corey’s parents say they would immediately travel abroad for further treatment in order to give Corey the very best chance of survival. – See more at:

Terms and Conditions for Journeys

All donations are paid into Solving Kids’ Cancer Europe’s general funds to further its general charitable purposes. The funds raised by this Journey are not restricted for the child’s use. However, the trustees of SKC have agreed to designate 93% of funds raised by this Journey to help the child and their family pay for potential future treatment costs and all other associated costs including travel and accommodation. We will use the remaining 7% to pay for some of SKC’s administrative and fundraising costs.

If the child no longer needs the funds, or if the trustees decide, at their absolute discretion, that the funds should be used for a different purpose, they may redesignate all or part of the 93% for SKC’s general charitable purposes. We are very grateful for your charitable donation.

Join our newsletter

For information and guidance on how Solving Kids’ Cancer manages your personal information please see our Privacy Policy

Privacy Policy (click to expand)

Follow Us

Useful links

Contact us

Solving Kids' Cancer

Tel: 020 7284 0800

CAN Mezzanine
49-51 East Road
N1 6AH

Contact us